http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105663096-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
filingDate | 2016-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105663096-B |
titleOfInvention | A kind of Wo Nuolazan oral quick-dissolving film preparation and preparation method thereof |
abstract | The invention discloses a kind of Wo Nuolazan oral quick-dissolving film preparations and preparation method thereof, belong to field of pharmaceutical preparations.Specifically, the oral quick-dissolving film preparation includes following component by weight percentage: Wo Nuolazan activated monomer 10-15%;Hydroxypropyl methylcellulose 50-55%;Maltodextrin 25-30%;Hyaluronic acid 0.8-1.0%;Plasticizer 5-10%.Oral quick-dissolving film preparation of the invention passes through preferred water-soluble hydroxypropyl methylcellulose, maltodextrin, hyaluronic acid as filmogen, and screens suitable plasticizer and its weight proportion, and the film of disintegration time and satisfactory mechanical property has been made.Oral quick-dissolving film preparation of the invention can dramatically speed up the disintegration time limited of film, and solving the disadvantage that most of oral solid formulation is taken at present needs water, will not delay medication time in the case where no water resource, improve the medication compliance of patient. |
priorityDate | 2016-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.